… compare the effectiveness and costs of using erlotinib, gefitinib, or afatinib in the treatment of
NSCLC. … was more effective at increasing PFS compared to erlotinib and afatinib. The cost-…

… gefitinib or erlotinib (12). Although afatinib has superior efficacy for brain metastasis compared
… (13), its efficacy for CNS metastasis has not been fully compared with other EGFR TKIs. In …

… describe the effectiveness and safety of afatinib, gefitinib, and erlotinib for elderly … afatinib
required dose reductions or discontinuation compared to those treated with gefitinib or erlotinib…

… The objective of this study was to compare the cost effectiveness of first-line epidermal
growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for the treatment of non-small-cell …

… studies have compared the cost-effectiveness of these four … the cost-effectiveness of erlotinib,
gefitinib, afatinib and osimertinib … A Markov model was constructed to compare the 10-year …

… NSCLC who progressed after prior treatment with erlotinib or gefitinib, which is similar …
afatinib because of AEs, there was no significant difference in the discontinuation rate compared …

… the cornerstone treatment of patients with non-small cell lung … study was to compare the
cost-effectiveness of three different … cost-effectiveness analysis determined that afatinib was a …

… Background/Aim: We investigated efficacy differences for afatinib versus gefitinib in non-small-…
trials showed no significant differences in efficacy between afatinib gefitinib, erlotinib, and …

… from differences in the frequency of mutation types in the populations concerned, especially
considering that most studies assessing the effectiveness of gefitinib and erlotinib were …

… Although bevacizumab in combination with afatinib or erlotinib is an effective and … non-small-cell
lung cancer (NSCLC), there are very few clinical data comparing afatinib and erlotinib …